K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?
Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first, leading the way, Jongkundang Bio and...
Search results for "clinical trials"
The “Stem Cell Injection” My Dermatologist Recommended — Is It Actually Stem Cell Therapy?
A, who has entered her mid-40s this year, has been feeling increasingly depressed when standing in front of the mirror lately.
Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears
Among breast cancers, ‘triple-negative breast cancer ’ is particularly challenging to treat.
HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA
HK Innoen announced on the 13th that its U.S. partner, Sevela Pharmaceuticals, a subsidiary and specialist in...
Korea University Anam Hospital Opens the First Specialized Center for Intractable Gastroesophageal Reflux Disease in the Country
Korea University Anam Hospital has opened the first specialized treatment center in the country for patients with...
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
Are One or Two Drinks Good for Your Health?…“Even One Drink a Day Threatens Heart Health”
A Korean study has been published that directly challenges the common belief that “one or two drinks are good for your...
Next-Generation Precision Medicine for Cancer Treatment... Amgen Acquires UK Biotech for 1 Trillion Won
Global pharmaceutical company Amgen is acquiring a UK biotech for up to $840 million (approximately 1.
When Ovarian Cancer is Detected, 70% Have Peritoneal Metastasis... Due to the Cancer Cells' 'Cunning Strategy'?
Ovarian cancer is often found at stages 3 or 4, with a high mortality rate of about 80%.
Samsung Bioepis to Directly Sell Ophthalmic Drug Baivubiz in Europe
Samsung Bioepis announced on the 4th that it has recovered the European commercialization rights for the ophthalmic...